|
Name |
Griseoxanthone C
|
Molecular Formula | C15H12O5 | |
IUPAC Name* |
1,6-dihydroxy-3-methoxy-8-methylxanthen-9-one
|
|
SMILES |
CC1=CC(=CC2=C1C(=O)C3=C(C=C(C=C3O2)OC)O)O
|
|
InChI |
InChI=1S/C15H12O5/c1-7-3-8(16)4-11-13(7)15(18)14-10(17)5-9(19-2)6-12(14)20-11/h3-6,16-17H,1-2H3
|
|
InChIKey |
UIKVQKMDLQHSKA-UHFFFAOYSA-N
|
|
Synonyms |
Griseoxanthone C; 3569-83-3; 1,6-dihydroxy-3-methoxy-8-methylxanthen-9-one; 1,6-Dihydroxy-3-methoxy-8-methyl-9H-xanthen-9-one; MJH6MPF38T; 9H-Xanthen-9-one, 1,6-dihydroxy-3-methoxy-8-methyl-; Xanthen-9-one, 1,6-dihydroxy-3-methoxy-8-methyl-; UNII-MJH6MPF38T; CHEMBL4081067; CHEBI:181512; DTXSID001234012; ZINC14815320; 3,8-dihydroxy-6-methoxy-1-methylxanthone; 1,6-dihydroxy-3-methoxy-8-methyl-xanthen-9-one; 1,6-Dihydroxy-3-methoxy-8-methyl-9H-xanthen-9-one #; NCGC00380279-01!1,6-dihydroxy-3-methoxy-8-methylxanthen-9-one
|
|
CAS | 3569-83-3 | |
PubChem CID | 5377910 | |
ChEMBL ID | CHEMBL4081067 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 272.25 | ALogp: | 3.1 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 76.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 20 | QED Weighted: | 0.663 |
Caco-2 Permeability: | -4.926 | MDCK Permeability: | 0.00000897 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.985 |
Human Intestinal Absorption (HIA): | 0.017 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.932 |
Blood-Brain-Barrier Penetration (BBB): | 0.014 | Plasma Protein Binding (PPB): | 93.31% |
Volume Distribution (VD): | 0.844 | Fu: | 9.18% |
CYP1A2-inhibitor: | 0.98 | CYP1A2-substrate: | 0.942 |
CYP2C19-inhibitor: | 0.548 | CYP2C19-substrate: | 0.07 |
CYP2C9-inhibitor: | 0.669 | CYP2C9-substrate: | 0.947 |
CYP2D6-inhibitor: | 0.793 | CYP2D6-substrate: | 0.894 |
CYP3A4-inhibitor: | 0.466 | CYP3A4-substrate: | 0.138 |
Clearance (CL): | 5.11 | Half-life (T1/2): | 0.686 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.09 |
Drug-inuced Liver Injury (DILI): | 0.907 | AMES Toxicity: | 0.483 |
Rat Oral Acute Toxicity: | 0.073 | Maximum Recommended Daily Dose: | 0.912 |
Skin Sensitization: | 0.841 | Carcinogencity: | 0.029 |
Eye Corrosion: | 0.264 | Eye Irritation: | 0.98 |
Respiratory Toxicity: | 0.417 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002523 | 0.774 | D0K8KX | 0.420 | ||||
ENC001574 | 0.754 | D04AIT | 0.413 | ||||
ENC001653 | 0.746 | D06GCK | 0.363 | ||||
ENC004846 | 0.746 | D07MGA | 0.333 | ||||
ENC005191 | 0.746 | D0FA2O | 0.275 | ||||
ENC005808 | 0.746 | D0G4KG | 0.271 | ||||
ENC006013 | 0.738 | D04UTT | 0.267 | ||||
ENC005647 | 0.672 | D0AZ8C | 0.254 | ||||
ENC005648 | 0.672 | D0G5UB | 0.250 | ||||
ENC005649 | 0.647 | D0TC7C | 0.238 |